GR3025499T3 - Farnesyl:protein transferase inhibitors as anticancer agents - Google Patents
Farnesyl:protein transferase inhibitors as anticancer agentsInfo
- Publication number
- GR3025499T3 GR3025499T3 GR970403148T GR970403148T GR3025499T3 GR 3025499 T3 GR3025499 T3 GR 3025499T3 GR 970403148 T GR970403148 T GR 970403148T GR 970403148 T GR970403148 T GR 970403148T GR 3025499 T3 GR3025499 T3 GR 3025499T3
- Authority
- GR
- Greece
- Prior art keywords
- farnesyl
- anticancer agents
- protein transferase
- transferase inhibitors
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C07F9/3821—Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3826—Acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C07F9/4012—Esters of acyclic acids which can have further substituents on alkyl substituted by B, Si, P or a metal
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2141193A | 1993-02-23 | 1993-02-23 | |
| PCT/US1994/000929 WO1994019357A1 (en) | 1993-02-23 | 1994-01-24 | Farnesyl:protein transferase inhibitors as anticancer agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3025499T3 true GR3025499T3 (en) | 1998-02-27 |
Family
ID=21804071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR970403148T GR3025499T3 (en) | 1993-02-23 | 1997-11-26 | Farnesyl:protein transferase inhibitors as anticancer agents |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5463181A (el) |
| EP (1) | EP0686159B1 (el) |
| JP (1) | JPH08509470A (el) |
| KR (1) | KR100305128B1 (el) |
| CN (1) | CN1045207C (el) |
| AT (1) | ATE159023T1 (el) |
| AU (1) | AU684071B2 (el) |
| CA (1) | CA2154871C (el) |
| DE (1) | DE69406110T2 (el) |
| DK (1) | DK0686159T3 (el) |
| ES (1) | ES2110738T3 (el) |
| FI (1) | FI111369B (el) |
| GR (1) | GR3025499T3 (el) |
| HU (1) | HUT72647A (el) |
| IL (1) | IL108694A0 (el) |
| NO (1) | NO306618B1 (el) |
| NZ (1) | NZ262585A (el) |
| TW (1) | TW265345B (el) |
| ZA (1) | ZA941099B (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| FR2833266B1 (fr) * | 2001-12-11 | 2004-10-22 | Mayoly Spindler Lab | Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2 |
| SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
| MX2009002893A (es) | 2006-09-18 | 2009-07-10 | Raptor Pharmaceutical Inc | Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap). |
| WO2010095940A2 (en) | 2009-02-20 | 2010-08-26 | To-Bbb Holding B.V. | Glutathione-based drug delivery system |
| NZ596876A (en) | 2009-05-06 | 2014-01-31 | Lab Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57142993A (en) * | 1981-02-28 | 1982-09-03 | Sagami Chem Res Center | 2-hydroxyphosphonic diester |
| DE3313070A1 (de) * | 1983-04-12 | 1984-10-18 | Bayer Ag, 5090 Leverkusen | Chlorierte phosphorylmethylcarbonyl-derivate, verfahren zu ihrer herstellung und ihre verwendung in pflanzenschutmitteln |
| DE3425701A1 (de) * | 1984-07-12 | 1986-01-16 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung |
| US4924024A (en) * | 1988-01-11 | 1990-05-08 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors, new intermediates and method |
| US5177239A (en) * | 1989-07-18 | 1993-01-05 | E. R. Squibb & Sons, Inc. | Method for preparing a phosphonic acid ester |
| US5298655A (en) * | 1991-09-27 | 1994-03-29 | Merck & Co., Inc. | Farnesyl pyrophosphate analogs |
-
1993
- 1993-11-08 US US08/148,188 patent/US5463181A/en not_active Expired - Fee Related
-
1994
- 1994-01-24 AU AU62324/94A patent/AU684071B2/en not_active Ceased
- 1994-01-24 EP EP94909497A patent/EP0686159B1/en not_active Expired - Lifetime
- 1994-01-24 DK DK94909497.3T patent/DK0686159T3/da active
- 1994-01-24 DE DE69406110T patent/DE69406110T2/de not_active Expired - Fee Related
- 1994-01-24 AT AT94909497T patent/ATE159023T1/de not_active IP Right Cessation
- 1994-01-24 NZ NZ262585A patent/NZ262585A/en unknown
- 1994-01-24 JP JP6518980A patent/JPH08509470A/ja not_active Ceased
- 1994-01-24 HU HU9502455A patent/HUT72647A/hu unknown
- 1994-01-24 CA CA002154871A patent/CA2154871C/en not_active Expired - Fee Related
- 1994-01-24 CN CN94191274A patent/CN1045207C/zh not_active Expired - Fee Related
- 1994-01-24 ES ES94909497T patent/ES2110738T3/es not_active Expired - Lifetime
- 1994-01-24 KR KR1019950703547A patent/KR100305128B1/ko not_active IP Right Cessation
- 1994-02-17 ZA ZA941099A patent/ZA941099B/xx unknown
- 1994-02-17 IL IL10869494A patent/IL108694A0/xx unknown
- 1994-02-18 TW TW083101358A patent/TW265345B/zh active
-
1995
- 1995-08-22 NO NO953292A patent/NO306618B1/no unknown
- 1995-08-22 FI FI953934A patent/FI111369B/fi active
-
1997
- 1997-11-26 GR GR970403148T patent/GR3025499T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI953934A0 (fi) | 1995-08-22 |
| ATE159023T1 (de) | 1997-10-15 |
| NZ262585A (en) | 1997-12-19 |
| FI953934A (fi) | 1995-08-22 |
| ZA941099B (en) | 1994-08-30 |
| HU9502455D0 (en) | 1995-10-30 |
| IL108694A0 (en) | 1994-05-30 |
| CA2154871C (en) | 1998-04-07 |
| NO306618B1 (no) | 1999-11-29 |
| JPH08509470A (ja) | 1996-10-08 |
| HUT72647A (en) | 1996-05-28 |
| EP0686159A1 (en) | 1995-12-13 |
| US5463181A (en) | 1995-10-31 |
| FI111369B (fi) | 2003-07-15 |
| NO953292D0 (no) | 1995-08-22 |
| EP0686159B1 (en) | 1997-10-08 |
| CN1045207C (zh) | 1999-09-22 |
| AU684071B2 (en) | 1997-12-04 |
| DE69406110T2 (de) | 1998-05-14 |
| TW265345B (el) | 1995-12-11 |
| CN1118166A (zh) | 1996-03-06 |
| CA2154871A1 (en) | 1994-09-01 |
| NO953292L (no) | 1995-08-22 |
| ES2110738T3 (es) | 1998-02-16 |
| KR100305128B1 (ko) | 2001-11-22 |
| DE69406110D1 (de) | 1997-11-13 |
| DK0686159T3 (da) | 1998-01-26 |
| AU6232494A (en) | 1994-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9320782D0 (en) | Stabilising of proteins on solution | |
| NZ297157A (en) | Amine derivatives with calcium ion receptor activity; medicaments containing such compounds | |
| GR3030312T3 (en) | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents | |
| MX173274B (es) | Metodos y composiciones biocidas para sistemas de agua recirculante | |
| ZA941099B (en) | Farnesyl: protein transferase inhibitors as anticancer agents | |
| GR3036754T3 (en) | Use of isoxazole- and crotonamide derivatives for the manufacture of a medicament for the treatment of cancers | |
| CO4290351A1 (es) | Proceso | |
| GB1198109A (en) | Aryl-Substituted Aliphatic Benzyl and Naphthyl-Methylene Quaternary Ammonium Compounds | |
| FI915044A (fi) | Korrosionsinhibitorer foer anvaendning i belaeggningskompositioner som innehaoller synergistiska kombinationer av kalciumborater och aminokarboxylater. | |
| AR247750A1 (es) | Sistema inhibidor de polimerizacion y composicion estabilizada que lo comprende. | |
| HUP9701382A2 (hu) | Új 7,8-dihidro-8-metil-9H-1,3-dioxolo-[4,5-h][2,3]-benzodiazepin-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmény, és eljárás a hatóanyag előállítására | |
| HUP9701383A2 (hu) | Új 8-metil-7H-1,3-dioxolo[4,5h][2,3]-benzodiazepin-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmény, és eljárás a hatóanyag előállítására | |
| ES8604532A1 (es) | Procedimiento de preparacion de nuevos derivados as-triazinos condensados | |
| MY103529A (en) | Antiarrhythmic agents | |
| CS743087A2 (en) | Herbicide and method of its effective substances production |